Abstract
Psoriasis is a chronic inflammatory disease and topical corticosteroids remain the mainstay of its treatment. Corticophobia, also called topical corticosteroid concerns (TCC), can cause poor adherence to treatment and impact disease control. It is defined as exaggerated fears, anxiety, doubts or reluctance regarding corticosteroid use.1 TCC has been evaluated by a numerical (NS) and a visual analog scale (VAS)2,3 , however, it´s complexity makes an assessment by binary (yes/no) questions too simplistic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the European Academy of Dermatology and Venereology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
